The Vocal Biomarkers Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of vocal biomarkers has seen quick expansion in recent times, climbing from $2.84 billion in 2024 to $3.37 billion in 2025. This represents a compound annual growth rate (CAGR) of 18.8%.
The Vocal Biomarkers market is projected to reach a size of $6.66 billion in 2029, growing at a compound annual growth rate (CAGR) of 18.6%.
Download Your Free Sample of the 2025 Vocal Biomarkers Market Report and Uncover Key Trends Now!The drivers in the vocal biomarkers market are:
• Need for early detection of diseases
• Vocal biomarker applications in lie detection
• Demand for vocal biomarkers in the defense sector
• Rising incidence of mental disorders and chronic diseases such as cardiovascular disease
The vocal biomarkers market covered in this report is segmented –
1) By Type: Frequency, Amplitude, Error Rate, Vocal Rise Or Fall Time, Phonation Time, Voice Tremor, Pitch, Other Types
2) By Indications: Psychiatric Disorders, Neurological Disorders, Respiratory Disorders, Cardiovascular Disorders, Traumatic Brain Injury (TBI), Other Indications
3) By Consumer: Children And Newborns, Adult
4) By End Users: Hospitals And Clinics, Academic, Research, Other End-Users
The trends in the vocal biomarkers market are:
• Advances in biomarker technology are shaping the future of the market.
• The market trends are heavily influenced by the rapid adoption of advanced technologies.
• The realm is witnessing a major trend of high investments in research and development.
• Improvements in diagnostic capabilities due to technological advancements in the medical industry are also formulating emerging trends.
The major players in the vocal biomarkers market are:
• The major companies that operate in the vocal biomarkers market include Hitachi Ltd.
North America was the largest region in the vocal biomarkers market in 2023